Mark P. Colonnese

2016 - Biota Pharmaceuticals

In 2016, Mark P. Colonnese earned a total compensation of $749.9K as Executive Vice President and Chief Financial Officer at Biota Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$48,400
Option Awards$291,713
Salary$233,750
Other$176,082
Total$749,945

Colonnese received $291.7K in option awards, accounting for 39% of the total pay in 2016.

Colonnese also received $48.4K in non-equity incentive plan, $233.8K in salary and $176.1K in other compensation.

Rankings

In 2016, Mark P. Colonnese's compensation ranked 9,573rd out of 14,075 executives tracked by ExecPay. In other words, Colonnese earned more than 32.0% of executives.

ClassificationRankingPercentile
All
9,573
out of 14,075
32nd
Division
Manufacturing
3,708
out of 5,489
32nd
Major group
Chemicals And Allied Products
1,290
out of 1,895
32nd
Industry group
Drugs
1,026
out of 1,538
33rd
Industry
Biological Products, Except Diagnostic Substances
178
out of 279
36th
Source: SEC filing on September 27, 2016.

Colonnese's colleagues

We found two more compensation records of executives who worked with Mark P. Colonnese at Biota Pharmaceuticals in 2016.

2016

Joseph Patti

Biota Pharmaceuticals

Chief Executive Officer

2016

Russell Plumb

Biota Pharmaceuticals

Chairman

News

You may also like